IntroductionChronic obstructive pulmonary disease (COPD) and lung cancer present major medical challenges; COPD is the third leading cause of death and lung cancer is the leading cause of cancer-related death in the United States (1,2). Several studies have established a relationship between COPD and lung cancer. The prevalence of COPD in newly-diagnosed lung cancer patients was estimated at about 50% (3) and COPD is considered an independent risk factor of lung cancer, irrespective of smoking history (4,5).Emphysema, one of the classic subtypes of COPD, is characterized by abnormal and permanent enlargement of airspaces distal to terminal bronchioles and accompanying destruction of alveolar walls. Computed tomography (CT) is an established method for the detection and quantification of emphysema (6,7), and CT-diagnosed emphysema has also been reported to be associated with an increased risk of lung cancer independently of smoking history and airflow obstruction (8). Furthermore, recent studies have reported that presence of emphysema detected by CT in resected Original Article